--Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal diseases with an emphasis on Gimoti ® nasal spray, today announced that the Company is ...

Parexel’s research draws from an extensive quantitative and qualitative survey of more than 500 senior leaders and frontline workers across pharmaceutical, biotech and CROs in the United States ...

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies TM (MET) dedicated to enhancing ...

Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development ABIONYX Pharma Announces Its 2023 Full-Year ...

Biotech and pharma companies saw their worst quarter for venture capital since 2019 in Q2 this year, according to a new report from Pitchbook and the National Venture Capital Association.

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 Provided by GlobeNewswire Mar 6, 2025, 1:30:28 PM.

--BridgeBio Pharma, Inc., a new type of biopharmaceutical company focused on genetic diseases, today announced that it will report financial results for the fourth quarter and full year ended ...